Showing results (1521-1530 of 2,109) with videos related to

Sort By:
Pageof 211
Molecular Cancer|December 23, 2008
LIM only 4 is overexpressed in late stage pancreas cancerJun Yu, Kenoki Ohuchida, Kohei Nakata, et al.
Kidney International|December 17, 2013
The cyclin-dependent kinase inhibitor p21 is essential for the beneficial effects of renal ischemic preconditioning on renal ischemia/reperfusion injury in miceSatoshi Nishioka, Daisuke Nakano, Kento Kitada, et al.
Journal of Sports Science & Medicine|December 13, 2019
Effects of Progressive Walking and Stair-Climbing Training Program on Muscle Size and Strength of the Lower Body in Untrained Older AdultsHayao Ozaki, Takashi Nakagata, Toshinori Yoshihara, et al.
Journal of Cardiology Cases|April 19, 2019
A successful case of percutaneous fistula closure in a patient with high output heart failure and extracardiac arteriovenous fistulaYukiko Kato, Takafumi Nakayama, Junki Yamamoto, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 15, 2021
Computed tomography to identify risk factors for left circumflex artery injury during mitral surgeryNoriaki Kishimoto, Yosuke Takahashi, Hiromichi Fujii, et al.
Japanese Clinical Medicine|January 29, 2015
A case of fetal intestinal volvulus without malrotation causing severe anemiaTomoko Nakagawa, Daisuke Tachibana, Kohei Kitada, et al.
Respiration; International Review of Thoracic Diseases|August 15, 2012
Pulmonary disease caused by rapidly growing mycobacteria: a retrospective study of 44 cases in JapanYukihiro Yano, Seigo Kitada, Masahide Mori, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|October 23, 2012
One-year follow-up of treatment with once-daily tacrolimus in de novo renal transplantHidehisa Kitada, Yasuhiro Okabe, Takehiro Nishiki, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 1, 1986
[General pharmacological action of tritoqualine (TRQ; (+/-)-(R*)-7-amino-4, 5, 6-triethoxy-3-[(R*)-5, 6, 7, 8-tetrahydro-4-methoxy-6-methyl-1, 3-dioxolo [4, 5-g] isoquinolin-5-yl] phthalide]A Narimatsu, K Nakao, M Egawa, et al.
Clinical and Experimental Pharmacology & Physiology|October 9, 2012
Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin systemSarka Varcabova, Zuzana Huskova, Herbert J Kramer, et al.
Pageof 211